JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rodés-Cabau, J.
Right arrow Articles by Soler-Soler, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rodés-Cabau, J.
Right arrow Articles by Soler-Soler, J.
Journal of Nuclear Medicine Vol. 42 No. 12 1768-1772
© 2001 by Society of Nuclear Medicine


Clinical Investigations

Frequency and Clinical Significance of Myocardial Ischemia Detected Early After Coronary Stent Implantation

Josep Rodés-Cabau, Jaume Candell-Riera, Enric Domingo, Joan Castell-Conesa, Inocencio Anívarro, Juan Angel, Santiago Aguadé-Bruix, Ferran Padilla, Adriana Soto and Jordi Soler-Soler

Servei de Cardiologia and Servei de Medicina Nuclear, Hospital General Universitari Vall d’Hebron, Barcelona, Spain

A high number (30%–50%) of reversible defects have been detected early after coronary balloon angioplasty. Inadequate luminal enlargement despite a good angiographic appearance has been suggested as a possible mechanism of these perfusion abnormalities, and some reports have shown better coronary flow reserve after coronary stent implantation than after balloon dilatation. The primary objective of this study was to evaluate the frequency of early ischemic defects detected by maximal exercise (plus dipyridamole) with 99mTc-tetrofosmin SPECT after successful coronary angioplasty with stent implantation. A secondary objective was to determine the prognostic value of these early ischemic defects. Methods: Thirty patients without previous myocardial infarction who successfully underwent 1-vessel coronary angioplasty with stent implantation were studied. Maximal-exercise 99mTc-tetrofosmin myocardial SPECT, with simultaneous dipyridamole if exercise was suboptimal, was performed at 6 ± 1 d (mean ± SD) after percutaneous transluminal coronary angioplasty. At 8 ± 3 mo, all patients were followed up clinically, and 77% of them underwent follow-up angiography. Results: The percentage of stenosis decreased from 68.5% ± 12.6% of luminal diameter to 9.3% ± 8.8% after stent implantation, and minimal luminal diameter increased from 0.89 ± 0.36 mm to 2.85 ± 0.45 mm. Mild-to-moderate reversible myocardial defects in the territory of the dilated artery were detected in 5 patients (17%), with no angiographic or procedural differences occurring between them and patients without ischemic defects. At follow-up, the target lesion revascularization rates depending on the presence or absence of early ischemic defects were 40% and 8%, respectively (P = 0.18). Angiographic restenosis occurred in 3 of 4 patients who had early ischemic defects and underwent follow-up angiography and in 3 of 19 patients who had no early ischemic defects and underwent follow-up angiography (restenosis rate, 75% and 16%, respectively; P < 0.05). Conclusion: Coronary angioplasty with stent implantation is associated with a 17% rate of ischemic defects early after the procedure. Patients with early myocardial perfusion defects after coronary stent implantation had a high rate of restenosis.

Key Words: coronary disease • stents • perfusion imaging




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
K. N. Giedd and S. R. Bergmann
Myocardial perfusion imaging following percutaneous coronary intervention: the importance of restenosis, disease progression, and directed reintervention
J. Am. Coll. Cardiol., February 4, 2004; 43(3): 328 - 336.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2001 by the Society of Nuclear Medicine.